Management Team

Concord Engineering Group's team of professional engineers possess a diversity of talent and experience that provides our clients with the knowledge, the background, the skill, and unique perspective on their projects.

Christine Fischette

Christine Fischette, Ph.D.

Board Advisor, Life Science / Pharma

Dr. Fischette is an Independent Board Director with over 30 years of experience in strategic and operational roles within research, drug development, commercialization, business development, general management, and Board oversight in the BioPharma industry. As CEO & Founder of BioLinkUp, LLC, she has consulted for investment banks, biotech companies, academic institutions, and non-profits. She was a faculty member for BIO's Business Development Fundamentals Course, offered annually by BIO. Previously, Dr. Fischette held Executive positions at NY investment banks, Torreya Partners, and Griffin Securities, as well as at Enzo Therapeutics, Novartis, Pfizer, and Hoffmann-LaRoche. She served as Head of Negotiation and Board Director for several therapeutic business units at Novartis. She frequently chairs, organizes, and speaks at International BioPharma conferences.

At Pfizer, she directed a therapeutic's entire drug development and marketing process from formulation selection to successful commercialization, with net sales eventually reaching $350 million. She has authored over 50 publications in peer-reviewed publications, including Science, while at Rockefeller University and other institutions.


  • Post-Doctorate/Research Associate, Neuroendocrinology
    Rockefeller University, New York, NY
  • Ph.D. Physiology
    Rutgers Biomedical Health Sciences (formerly UMDNJ), Newark, NJ
  • Bachelor of Arts, Biology
    Rutgers University, Newark, NJ


  • 2021 – Present
    Concord Engineering Group, Inc. | Board Advisor, Life Science / Pharma
  • 2010 – Present
    BioLinkUp, LLC | Chief Executive Officer
    A Corporate Strategy / Business Development Entity
  • 2021 – Present
    Antag Therapeutics, ApS |
    Independent Board Director, Copenhagen, Capital Region, Denmark
    Therapeutic peptides for the treatment of dietary-related metabolic diseases, especially obesity and diabetes, among other indications
  • 2015 – 2021
    Torreya Partners, Inc., New York, NY | Executive Director
    Boutique investment bank focused on the BioPharma industry
  • 2010 – 2015
    Griffin Securities Inc., New York, NY | Senior Advisor
    Boutique investment bank – all industries
  • 2008 – 2010
    Enzo Theraputics, Inc., a Division of Enzo Biochem (ENZ: NYSE) | President
  • 1999 – 2007
    Novartis, Inc. | Head, Negotiation, Global Business Development & Licensing
    Search, Evaluation, Negotiation, Execution of Global Deals
  • 1987 – 1999
    Pfizer, Inc. | Executive positions in Research, Clinical Development, Marketing (US Head of Diabetes Franchise), Global Business Development & Licensing
  • 1983 – 1986
    Hoffmann-La Roche, Inc. | Senior Scientist